Mitsubishi UFJ Asset Management
PDLI

Mitsubishi UFJ Asset Management’s PDL BioPharma, Inc. PDLI Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-23,800
Closed -$120K – 878
2015
Q3 		$120K Hold
23,800
– – ﹤0.01% 773
2015
Q2 		$153K Hold
23,800
– – ﹤0.01% 776
2015
Q1 		$167K Hold
23,800
– – ﹤0.01% 756
2014
Q4 		$183K Hold
23,800
– – 0.01% 739
2014
Q3 		$178K Sell
23,800
-13,900
-37% -$129K 0.01% 726
2014
Q2 		$365K Buy
37,700
+4,100
+12% +$36.5K 0.01% 669
2014
Q1 		$279K Buy
+33,600
New +$288K 0.01% 677

Other funds holding PDLI

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Mitsubishi UFJ Asset Management's PDLI Position: Q4 2015 in Review

Mitsubishi UFJ Asset Management sold out of PDL BioPharma, Inc. (PDLI) in Q4 2015, closing a stake of 23,800 shares — an estimated $120K sold.

Mitsubishi UFJ Asset Management first reported a position in PDLI in Q1 2014 and held it in 7 quarters. The position peaked at $365K in Q2 2014. 204 funds tracked by Wall St. Rank hold PDLI as of Q4 2015.

  • Mitsubishi UFJ Asset Management reported no remaining PDL BioPharma, Inc. position as of Q4 2015 after selling out during the quarter.
  • Mitsubishi UFJ Asset Management sold 23,800 PDL BioPharma, Inc. shares in Q4 2015, an estimated $120K.
  • Mitsubishi UFJ Asset Management first reported a position in PDL BioPharma, Inc. in Q1 2014 and held it in 7 quarters.
  • Mitsubishi UFJ Asset Management's PDL BioPharma, Inc. position peaked at $365K in Q2 2014.
  • 204 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2015.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q4 2015, filed 10 Feb 2016.